1 Introduction to Research & Analysis Reports
1.1 Medical Antifungal Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Antifungal Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Antifungal Agent Overall Market Size
2.1 Global Medical Antifungal Agent Market Size: 2022 VS 2029
2.2 Global Medical Antifungal Agent Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical Antifungal Agent Sales: 2018-2029
3 Company Landscape
3.1 Top Medical Antifungal Agent Players in Global Market
3.2 Top Global Medical Antifungal Agent Companies Ranked by Revenue
3.3 Global Medical Antifungal Agent Revenue by Companies
3.4 Global Medical Antifungal Agent Sales by Companies
3.5 Global Medical Antifungal Agent Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical Antifungal Agent Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical Antifungal Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Antifungal Agent Players in Global Market
3.8.1 List of Global Tier 1 Medical Antifungal Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Antifungal Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Antifungal Agent Market Size Markets, 2022 & 2029
4.1.2 Azoles
4.1.3 Echinocandins
4.1.4 Polyenes
4.1.5 Allylamines
4.1.6 Others
4.2 By Type – Global Medical Antifungal Agent Revenue & Forecasts
4.2.1 By Type – Global Medical Antifungal Agent Revenue, 2018-2023
4.2.2 By Type – Global Medical Antifungal Agent Revenue, 2024-2029
4.2.3 By Type – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
4.3 By Type – Global Medical Antifungal Agent Sales & Forecasts
4.3.1 By Type – Global Medical Antifungal Agent Sales, 2018-2023
4.3.2 By Type – Global Medical Antifungal Agent Sales, 2024-2029
4.3.3 By Type – Global Medical Antifungal Agent Sales Market Share, 2018-2029
4.4 By Type – Global Medical Antifungal Agent Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical Antifungal Agent Market Size, 2022 & 2029
5.1.2 Dermatophytosis
5.1.3 Aspergillosis
5.1.4 Candidiasis
5.1.5 Others
5.2 By Application – Global Medical Antifungal Agent Revenue & Forecasts
5.2.1 By Application – Global Medical Antifungal Agent Revenue, 2018-2023
5.2.2 By Application – Global Medical Antifungal Agent Revenue, 2024-2029
5.2.3 By Application – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
5.3 By Application – Global Medical Antifungal Agent Sales & Forecasts
5.3.1 By Application – Global Medical Antifungal Agent Sales, 2018-2023
5.3.2 By Application – Global Medical Antifungal Agent Sales, 2024-2029
5.3.3 By Application – Global Medical Antifungal Agent Sales Market Share, 2018-2029
5.4 By Application – Global Medical Antifungal Agent Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medical Antifungal Agent Market Size, 2022 & 2029
6.2 By Region – Global Medical Antifungal Agent Revenue & Forecasts
6.2.1 By Region – Global Medical Antifungal Agent Revenue, 2018-2023
6.2.2 By Region – Global Medical Antifungal Agent Revenue, 2024-2029
6.2.3 By Region – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
6.3 By Region – Global Medical Antifungal Agent Sales & Forecasts
6.3.1 By Region – Global Medical Antifungal Agent Sales, 2018-2023
6.3.2 By Region – Global Medical Antifungal Agent Sales, 2024-2029
6.3.3 By Region – Global Medical Antifungal Agent Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medical Antifungal Agent Revenue, 2018-2029
6.4.2 By Country – North America Medical Antifungal Agent Sales, 2018-2029
6.4.3 US Medical Antifungal Agent Market Size, 2018-2029
6.4.4 Canada Medical Antifungal Agent Market Size, 2018-2029
6.4.5 Mexico Medical Antifungal Agent Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medical Antifungal Agent Revenue, 2018-2029
6.5.2 By Country – Europe Medical Antifungal Agent Sales, 2018-2029
6.5.3 Germany Medical Antifungal Agent Market Size, 2018-2029
6.5.4 France Medical Antifungal Agent Market Size, 2018-2029
6.5.5 U.K. Medical Antifungal Agent Market Size, 2018-2029
6.5.6 Italy Medical Antifungal Agent Market Size, 2018-2029
6.5.7 Russia Medical Antifungal Agent Market Size, 2018-2029
6.5.8 Nordic Countries Medical Antifungal Agent Market Size, 2018-2029
6.5.9 Benelux Medical Antifungal Agent Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medical Antifungal Agent Revenue, 2018-2029
6.6.2 By Region – Asia Medical Antifungal Agent Sales, 2018-2029
6.6.3 China Medical Antifungal Agent Market Size, 2018-2029
6.6.4 Japan Medical Antifungal Agent Market Size, 2018-2029
6.6.5 South Korea Medical Antifungal Agent Market Size, 2018-2029
6.6.6 Southeast Asia Medical Antifungal Agent Market Size, 2018-2029
6.6.7 India Medical Antifungal Agent Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medical Antifungal Agent Revenue, 2018-2029
6.7.2 By Country – South America Medical Antifungal Agent Sales, 2018-2029
6.7.3 Brazil Medical Antifungal Agent Market Size, 2018-2029
6.7.4 Argentina Medical Antifungal Agent Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical Antifungal Agent Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medical Antifungal Agent Sales, 2018-2029
6.8.3 Turkey Medical Antifungal Agent Market Size, 2018-2029
6.8.4 Israel Medical Antifungal Agent Market Size, 2018-2029
6.8.5 Saudi Arabia Medical Antifungal Agent Market Size, 2018-2029
6.8.6 UAE Medical Antifungal Agent Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Medical Antifungal Agent Major Product Offerings
7.1.4 Novartis Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Medical Antifungal Agent Major Product Offerings
7.2.4 Pfizer Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Medical Antifungal Agent Major Product Offerings
7.3.4 Bayer Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Medical Antifungal Agent Major Product Offerings
7.4.4 Sanofi Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Merck & Co
7.5.1 Merck & Co Company Summary
7.5.2 Merck & Co Business Overview
7.5.3 Merck & Co Medical Antifungal Agent Major Product Offerings
7.5.4 Merck & Co Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Medical Antifungal Agent Major Product Offerings
7.6.4 GlaxoSmithKline Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 MSD Manuals
7.7.1 MSD Manuals Company Summary
7.7.2 MSD Manuals Business Overview
7.7.3 MSD Manuals Medical Antifungal Agent Major Product Offerings
7.7.4 MSD Manuals Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.7.5 MSD Manuals Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Medical Antifungal Agent Major Product Offerings
7.8.4 Abbott Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.8.5 Abbott Key News & Latest Developments
7.9 Glenmark
7.9.1 Glenmark Company Summary
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Medical Antifungal Agent Major Product Offerings
7.9.4 Glenmark Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.9.5 Glenmark Key News & Latest Developments
7.10 Enzon Pharmaceuticals
7.10.1 Enzon Pharmaceuticals Company Summary
7.10.2 Enzon Pharmaceuticals Business Overview
7.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Major Product Offerings
7.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.10.5 Enzon Pharmaceuticals Key News & Latest Developments
7.11 Astellas Pharma
7.11.1 Astellas Pharma Company Summary
7.11.2 Astellas Pharma Medical Antifungal Agent Business Overview
7.11.3 Astellas Pharma Medical Antifungal Agent Major Product Offerings
7.11.4 Astellas Pharma Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.11.5 Astellas Pharma Key News & Latest Developments
7.12 Scynexis
7.12.1 Scynexis Company Summary
7.12.2 Scynexis Medical Antifungal Agent Business Overview
7.12.3 Scynexis Medical Antifungal Agent Major Product Offerings
7.12.4 Scynexis Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.12.5 Scynexis Key News & Latest Developments
7.13 Cidara Therapeutics
7.13.1 Cidara Therapeutics Company Summary
7.13.2 Cidara Therapeutics Medical Antifungal Agent Business Overview
7.13.3 Cidara Therapeutics Medical Antifungal Agent Major Product Offerings
7.13.4 Cidara Therapeutics Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.13.5 Cidara Therapeutics Key News & Latest Developments
7.14 Lucigen Corporation
7.14.1 Lucigen Corporation Company Summary
7.14.2 Lucigen Corporation Business Overview
7.14.3 Lucigen Corporation Medical Antifungal Agent Major Product Offerings
7.14.4 Lucigen Corporation Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.14.5 Lucigen Corporation Key News & Latest Developments
7.15 Biosergen
7.15.1 Biosergen Company Summary
7.15.2 Biosergen Business Overview
7.15.3 Biosergen Medical Antifungal Agent Major Product Offerings
7.15.4 Biosergen Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.15.5 Biosergen Key News & Latest Developments
7.16 F2G
7.16.1 F2G Company Summary
7.16.2 F2G Business Overview
7.16.3 F2G Medical Antifungal Agent Major Product Offerings
7.16.4 F2G Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.16.5 F2G Key News & Latest Developments
7.17 Sichuan Meidakang Pharmaceutical
7.17.1 Sichuan Meidakang Pharmaceutical Company Summary
7.17.2 Sichuan Meidakang Pharmaceutical Business Overview
7.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Major Product Offerings
7.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.17.5 Sichuan Meidakang Pharmaceutical Key News & Latest Developments
7.18 Chengdu Taihe Health Technology
7.18.1 Chengdu Taihe Health Technology Company Summary
7.18.2 Chengdu Taihe Health Technology Business Overview
7.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Major Product Offerings
7.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.18.5 Chengdu Taihe Health Technology Key News & Latest Developments
8 Global Medical Antifungal Agent Production Capacity, Analysis
8.1 Global Medical Antifungal Agent Production Capacity, 2018-2029
8.2 Medical Antifungal Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Antifungal Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Antifungal Agent Supply Chain Analysis
10.1 Medical Antifungal Agent Industry Value Chain
10.2 Medical Antifungal Agent Upstream Market
10.3 Medical Antifungal Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Antifungal Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
※参考情報 医療用抗真菌剤は、真菌感染症に対抗するために使用される薬剤です。真菌は、菌類に属する微生物であり、人体において様々な感染症を引き起こす可能性があります。これらの感染症は、軽微なものから重篤なものまで多岐にわたります。抗真菌剤は、これらの真菌による感染の予防および治療に特化した薬剤であり、感染の種類や重症度に応じて多様な種類が存在します。 抗真菌剤の特徴には、主にその作用機序、適応する真菌の範囲、副作用の観点が含まれます。一般的な抗真菌剤は、真菌の細胞膜や細胞壁を標的とし、その構造を破壊することによって効果を発揮します。例えば、アゾール系抗真菌剤は、真菌の細胞膜に存在するエルゴステロールの合成を阻害し、これにより真菌の成長を抑制します。また、ポリエン系抗真菌剤は、真菌の細胞膜に直接結合し、膜の透過性を変化させることで、真菌の細胞死を引き起こします。 抗真菌剤は主に、アゾール系、ポリエン系、エキノカンジン系、アリルアミン系、その他の薬剤に分類されます。アゾール系薬剤には、フルコナゾールやイテラコナゾールがあり、主に内部感染に用いられます。ポリエン系薬剤には、アムホテリシンBやナイスタチンが含まれ、主に重症のカンジダ感染やクリプトコッカス感染に使用されます。エキノカンジン系薬剤は、カンジダやアスペルギルスに対して強力な効果を発揮し、一般的には、カポフング(カポフン酸)などがそれにあたります。アリルアミン系薬剤では、テルビナフィンが有名で、主に皮膚真菌症の治療に使用されます。 これらの抗真菌剤の使用は、真菌感染症の診療において非常に重要です。特に、免疫力が低下している患者や、長期療法を受けている患者においては、真菌感染症のリスクが高まるため、適切な抗真菌剤の選択と使用が求められます。真菌感染症は、その多様性と治療の難しさから、感染症治療の中でも特に注意を要する領域となっています。 抗真菌剤には、副作用も存在します。例えば、アゾール系の薬剤は、肝機能に影響を与える可能性があり、長期間使用する際には定期的な肝機能検査が推奨されます。ポリエン系の薬剤は、腎機能への影響があるため、腎障害を有する患者には慎重な使用が必要です。また、アリルアミン系の薬剤でも、皮膚や肝臓に関する副作用が報告されています。 関連技術としては、次世代シーケンシングやPCR技術などが挙げられます。これらの技術は、感染している真菌の種類を特定するために使用され、効果的な治療戦略の構築に寄与します。さらに、抗真菌剤に対する耐性の問題も深刻であり、新たな抗真菌剤の開発が急務とされています。耐性菌の出現は、特に免疫抑制患者や病院内感染の患者において大きな問題であるため、新しい作用機序を持つ薬剤の研究が進められています。 医療用抗真菌剤は、現代の医療において非常に重要な役割を果たしています。真菌感染症のリスクを軽減し、患者の健康を守るためには、これらの薬剤の理解と正しい使用が欠かせません。今後も、さらに効果的な抗真菌治療法の開発が期待されるとともに、真菌感染症に対する意識の向上が求められています。 |